MediWound Ltd.
MDWD
$17.40
$0.070.40%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -68.03% | 12.74% | 9.40% | -8.81% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -68.03% | 12.74% | 9.40% | -8.81% | |
| Cost of Revenue | -67.81% | -5.42% | 6.88% | -5.21% | |
| Gross Profit | -69.21% | 200.22% | 25.59% | -24.44% | |
| SG&A Expenses | -9.58% | 17.61% | 43.27% | 23.81% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -194.44% | -- | -91.96% | -- | |
| Total Operating Expenses | -19.04% | 19.66% | 26.45% | 20.96% | |
| Operating Income | -27.85% | -27.48% | -48.62% | -67.97% | |
| Income Before Tax | -82.78% | -110.56% | -139.68% | -377.70% | |
| Income Tax Expenses | 305.56% | 2,000.00% | -85.00% | -56.25% | |
| Earnings from Continuing Operations | -83.80% | -111.23% | -124.21% | -368.21% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -83.80% | -111.23% | -124.21% | -368.21% | |
| EBIT | -27.85% | -27.48% | -48.62% | -67.97% | |
| EBITDA | -27.76% | -28.96% | -50.80% | -75.73% | |
| EPS Basic | -54.64% | -80.88% | -91.64% | -310.66% | |
| Normalized Basic EPS | -53.79% | -80.32% | 67.23% | -- | |
| EPS Diluted | -54.64% | -80.88% | -91.64% | -310.66% | |
| Normalized Diluted EPS | -53.79% | -80.32% | 67.23% | -- | |
| Average Basic Shares Outstanding | 18.85% | 16.77% | 17.04% | 14.04% | |
| Average Diluted Shares Outstanding | 18.85% | 16.77% | 17.04% | 14.04% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |